Anteris Technologies Ltd (ASX:AVR)
Share Pricing & News Healthcare

AUD 23

-0.51 (2.169%)
(As on 2022-12-07 10:05:25 AEDT)
Previous Close Open Close*
23.51 23.61 23
Market Cap Dividend Yield (Annualized)
AUD 319.705M 0.00%

Day Range
22.62L 23.69 H
52 WEEK HIGH LOW
8L 30.89 H

Chart Price & Information

Last Trade 23
Change% -2.1693
52 W H/L 30.890/8.000
EBITDA -31.755M
NPAT After Abnormal Items -22.907M
Equity 14.348M
ROE% -159.65%
Total Liabilities 15.134M
Total Revenue 9.845M
Cash and Cash Equivalents 21.3M

Stock Information

Share price 23
Market Cap 319.705M
Price/Gross Cash Flow -10.51
Dividend Yield Excluding Special 0.00%
Ending Shares 11.094M
52-Week Range 30.890-8.000
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 1.19
P/E ratio 0.000
Sector P/E --
EPS -309.00
EV/EBITDA --
Net Profit Margin (%) -294.02%
Gross Cash Flows Per Share -1.85
Net Gearing -108.52%
Sales Per Share 1.05
Book Value Per Share 1.29

Similar Companies

Related Articles

About Company

ASX-listed structural heart company Anteris Technologies Ltd (ASX:AVR) is engaged in delivering clinically enhanced and durable solutions with better design and better science. The Company’s focus is to develop next-generation technologies to help healthcare specialists generate life-changing solutions for patients. The Company is developing The Anteris DurAVR™ aortic replacement valve to address the need for a superior hemodynamic profile.

Corporate Information


Toowong Tower, Level 3, 9 Sherwood Rd, TOOWONG, QLD, AUSTRALIA, 4066

Phone:+61 1300 550 310

Website:http://www.anteristech.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2023-08-23 2023
Report (Annual) 2023-04-25 2023
Report (Prelim) 2023-02-24 2023